181 related articles for article (PubMed ID: 34884997)
21. Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells.
Renosi F; Callanan M; Lefebvre C
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077669
[TBL] [Abstract][Full Text] [Related]
22. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.
Menezes J; Acquadro F; Wiseman M; Gómez-López G; Salgado RN; Talavera-Casañas JG; Buño I; Cervera JV; Montes-Moreno S; Hernández-Rivas JM; Ayala R; Calasanz MJ; Larrayoz MJ; Brichs LF; Gonzalez-Vicent M; Pisano DG; Piris MA; Álvarez S; Cigudosa JC
Leukemia; 2014 Apr; 28(4):823-9. PubMed ID: 24072100
[TBL] [Abstract][Full Text] [Related]
23. Mutations of myelodysplastic syndromes (MDS): An update.
Ganguly BB; Kadam NN
Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
[TBL] [Abstract][Full Text] [Related]
24. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
Ding Y; Yang J; Lindsey K
Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895
[TBL] [Abstract][Full Text] [Related]
25. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Itzykson R; Kosmider O; Renneville A; Gelsi-Boyer V; Meggendorfer M; Morabito M; Berthon C; Adès L; Fenaux P; Beyne-Rauzy O; Vey N; Braun T; Haferlach T; Dreyfus F; Cross NC; Preudhomme C; Bernard OA; Fontenay M; Vainchenker W; Schnittger S; Birnbaum D; Droin N; Solary E
J Clin Oncol; 2013 Jul; 31(19):2428-36. PubMed ID: 23690417
[TBL] [Abstract][Full Text] [Related]
26. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
[TBL] [Abstract][Full Text] [Related]
27. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
28. [Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
Sukegawa S; Sakata-Yanagimoto M; Matsuoka R; Momose H; Kiyoki Y; Noguchi M; Nakamura N; Watanabe R; Fujimoto M; Yokoyama Y; Nishikii H; Kato T; Kusakabe M; Kurita N; Obara N; Hasegawa Y; Chiba S
Rinsho Ketsueki; 2018; 59(12):2567-2573. PubMed ID: 30626790
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
[TBL] [Abstract][Full Text] [Related]
30. Blastic plasmacytoid dendritic cell neoplasm: A case report.
Wang W; Li W; Jia JJ; Zheng Y; Wang H; Gao XM; Dong XY; Tian Q; Jing HL; Wang X; Xiao SX
Oncol Lett; 2015 Mar; 9(3):1388-1392. PubMed ID: 25663917
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.
Tang Z; Tang G; Wang SA; Lu X; Young KH; Bueso-Ramos CE; Alvarado Y; Medeiros LJ; Khoury JD
Mol Cytogenet; 2016; 9():23. PubMed ID: 26925167
[TBL] [Abstract][Full Text] [Related]
32. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention.
Prochaska L; Dakhil C; Mathur S
Clin Med Insights Case Rep; 2013; 6():201-4. PubMed ID: 24385715
[TBL] [Abstract][Full Text] [Related]
33. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A
Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087
[TBL] [Abstract][Full Text] [Related]
34. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.
Stengel A; Baer C; Walter W; Meggendorfer M; Kern W; Haferlach T; Haferlach C
Blood Adv; 2021 Nov; 5(21):4426-4434. PubMed ID: 34570179
[TBL] [Abstract][Full Text] [Related]
35. Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.
Amitay-Laish I; Sundram U; Hoppe RT; Hodak E; Medeiros BC; Kim YH
JAAD Case Rep; 2017 Jul; 3(4):310-315. PubMed ID: 28752118
[No Abstract] [Full Text] [Related]
36. [Clinical characteristics of 6 patients with blastic plasmacytoid dendritic cell neoplasm].
Han X; Ouyang MQ; Pei Q; Duan MH; Jiang XY; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):700-705. PubMed ID: 28954350
[No Abstract] [Full Text] [Related]
37. Blastic plasmacytoid dendritic cell neoplasm in children: A review of two cases.
Deng W; Yang M; Kuang F; Liu Y; Zhang H; Cao L; Xie M; Yang L
Mol Clin Oncol; 2017 Oct; 7(4):709-715. PubMed ID: 28856005
[TBL] [Abstract][Full Text] [Related]
38. Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.
Sapienza MR; Abate F; Melle F; Orecchioni S; Fuligni F; Etebari M; Tabanelli V; Laginestra MA; Pileri A; Motta G; Rossi M; Agostinelli C; Sabattini E; Pimpinelli N; Truni M; Falini B; Cerroni L; Talarico G; Piccioni R; Amente S; Indio V; Tarantino G; Brundu F; Paulli M; Berti E; Facchetti F; Dellino GI; Bertolini F; Tripodo C; Rabadan R; Pileri SA
Haematologica; 2019 Apr; 104(4):729-737. PubMed ID: 30381297
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
Fan LF; Xu J; Chen XH; Tian TT; Xie J; Hu JJ; Guo ZP; Tan YH; Xu ZF; Ren FG; Zhang YF; Luo M; Ren WX; Wang HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):781-788. PubMed ID: 32552936
[TBL] [Abstract][Full Text] [Related]
40. Comparison of gene mutation spectra in younger and older Chinese acute myeloid leukemia patients and its prognostic value.
Zhong WJ; Liu XD; Zhong LY; Li KB; Sun QX; Xu X; Wei T; Li QS; Zhu ZG
Gene; 2021 Feb; 770():145344. PubMed ID: 33333221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
